CS256383B2 - Reagent for specific determination of pancreas alpha-amylase - Google Patents
Reagent for specific determination of pancreas alpha-amylase Download PDFInfo
- Publication number
- CS256383B2 CS256383B2 CS848967A CS896784A CS256383B2 CS 256383 B2 CS256383 B2 CS 256383B2 CS 848967 A CS848967 A CS 848967A CS 896784 A CS896784 A CS 896784A CS 256383 B2 CS256383 B2 CS 256383B2
- Authority
- CS
- Czechoslovakia
- Prior art keywords
- amylase
- alpha
- pancreatic
- salivary
- reagent
- Prior art date
Links
- 102000004139 alpha-Amylases Human genes 0.000 title claims description 24
- 108090000637 alpha-Amylases Proteins 0.000 title claims description 24
- 229940024171 alpha-amylase Drugs 0.000 title claims description 22
- 239000003153 chemical reaction reagent Substances 0.000 title claims description 7
- 210000000496 pancreas Anatomy 0.000 title description 2
- 108010029785 Pancreatic alpha-Amylases Proteins 0.000 claims description 12
- 102100026367 Pancreatic alpha-amylase Human genes 0.000 claims description 12
- 102100033770 Alpha-amylase 1C Human genes 0.000 claims description 10
- 108010026386 Salivary alpha-Amylases Proteins 0.000 claims description 10
- 230000000694 effects Effects 0.000 claims description 10
- 239000003112 inhibitor Substances 0.000 claims description 7
- 210000002966 serum Anatomy 0.000 claims description 6
- 210000001124 body fluid Anatomy 0.000 claims description 5
- 239000010839 body fluid Substances 0.000 claims description 5
- 238000003556 assay Methods 0.000 claims description 4
- 230000002183 duodenal effect Effects 0.000 claims description 4
- 235000011389 fruit/vegetable juice Nutrition 0.000 claims description 4
- 210000002700 urine Anatomy 0.000 claims description 4
- 229920002472 Starch Polymers 0.000 claims description 3
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 claims description 3
- 235000019698 starch Nutrition 0.000 claims description 3
- 102100031126 6-phosphogluconolactonase Human genes 0.000 claims description 2
- 108010029731 6-phosphogluconolactonase Proteins 0.000 claims description 2
- 108090001003 Beta-phosphoglucomutases Proteins 0.000 claims description 2
- 108010018962 Glucosephosphate Dehydrogenase Proteins 0.000 claims description 2
- 102100024295 Maltase-glucoamylase Human genes 0.000 claims description 2
- 108010028144 alpha-Glucosidases Proteins 0.000 claims description 2
- 125000006501 nitrophenyl group Chemical group 0.000 claims 2
- 239000008107 starch Substances 0.000 claims 1
- 239000004382 Amylase Substances 0.000 description 27
- 102000013142 Amylases Human genes 0.000 description 27
- 108010065511 Amylases Proteins 0.000 description 27
- 235000019418 amylase Nutrition 0.000 description 27
- 210000003079 salivary gland Anatomy 0.000 description 23
- 102000004190 Enzymes Human genes 0.000 description 12
- 108090000790 Enzymes Proteins 0.000 description 12
- 229940088598 enzyme Drugs 0.000 description 12
- 239000002244 precipitate Substances 0.000 description 9
- 241000699670 Mus sp. Species 0.000 description 8
- 238000000034 method Methods 0.000 description 8
- 241001494479 Pecora Species 0.000 description 7
- 230000003053 immunization Effects 0.000 description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- 206010003445 Ascites Diseases 0.000 description 6
- 210000003567 ascitic fluid Anatomy 0.000 description 6
- 239000000872 buffer Substances 0.000 description 6
- 210000004027 cell Anatomy 0.000 description 6
- 238000002649 immunization Methods 0.000 description 6
- 108040007629 peroxidase activity proteins Proteins 0.000 description 6
- 102000013415 peroxidase activity proteins Human genes 0.000 description 6
- 239000006228 supernatant Substances 0.000 description 6
- 230000008033 biological extinction Effects 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- 230000027455 binding Effects 0.000 description 4
- 239000012634 fragment Substances 0.000 description 4
- 239000008363 phosphate buffer Substances 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 3
- 241000209140 Triticum Species 0.000 description 3
- 235000021307 Triticum Nutrition 0.000 description 3
- 238000005119 centrifugation Methods 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 230000037029 cross reaction Effects 0.000 description 3
- 230000004927 fusion Effects 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 210000004989 spleen cell Anatomy 0.000 description 3
- 239000000758 substrate Substances 0.000 description 3
- FSRMLWKBCQFLJA-HTZQGQHSSA-N (2r,3r,4s,5s,6r)-2-[(2r,3s,4r,5r,6r)-6-[(2r,3s,4r,5r,6r)-6-[(2r,3s,4r,5r,6r)-6-[(2r,3s,4r,5r,6r)-6-[(2r,3s,4r,5r,6r)-6-[(2r,3s,4r,5r,6r)-4,5-dihydroxy-2-(hydroxymethyl)-6-(4-nitrophenoxy)oxan-3-yl]oxy-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-4,5-dihyd Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)O[C@H](O[C@@H]2[C@H](O[C@H](O[C@@H]3[C@H](O[C@H](O[C@@H]4[C@H](O[C@H](O[C@@H]5[C@H](O[C@H](O[C@@H]6[C@H](O[C@H](OC=7C=CC(=CC=7)[N+]([O-])=O)[C@H](O)[C@H]6O)CO)[C@H](O)[C@H]5O)CO)[C@H](O)[C@H]4O)CO)[C@H](O)[C@H]3O)CO)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FSRMLWKBCQFLJA-HTZQGQHSSA-N 0.000 description 2
- KFTBCJUZVUOWRL-UHFFFAOYSA-N 1-fluoro-2,3-dinitrobenzene Chemical compound [O-][N+](=O)C1=CC=CC(F)=C1[N+]([O-])=O KFTBCJUZVUOWRL-UHFFFAOYSA-N 0.000 description 2
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 2
- 238000002965 ELISA Methods 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 241000699666 Mus <mouse, genus> Species 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 239000003392 amylase inhibitor Substances 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 239000000427 antigen Substances 0.000 description 2
- 102000036639 antigens Human genes 0.000 description 2
- 108091007433 antigens Proteins 0.000 description 2
- 229940098773 bovine serum albumin Drugs 0.000 description 2
- 238000004113 cell culture Methods 0.000 description 2
- 210000000416 exudates and transudate Anatomy 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 229920001542 oligosaccharide Polymers 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- 101710171801 Alpha-amylase inhibitor Proteins 0.000 description 1
- 241000588832 Bordetella pertussis Species 0.000 description 1
- 206010053567 Coagulopathies Diseases 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 108010044467 Isoenzymes Proteins 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 229920000881 Modified starch Polymers 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 239000006146 Roswell Park Memorial Institute medium Substances 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 239000004411 aluminium Substances 0.000 description 1
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 1
- 210000004102 animal cell Anatomy 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 238000005349 anion exchange Methods 0.000 description 1
- OHDRQQURAXLVGJ-HLVWOLMTSA-N azane;(2e)-3-ethyl-2-[(e)-(3-ethyl-6-sulfo-1,3-benzothiazol-2-ylidene)hydrazinylidene]-1,3-benzothiazole-6-sulfonic acid Chemical compound [NH4+].[NH4+].S/1C2=CC(S([O-])(=O)=O)=CC=C2N(CC)C\1=N/N=C1/SC2=CC(S([O-])(=O)=O)=CC=C2N1CC OHDRQQURAXLVGJ-HLVWOLMTSA-N 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 239000012888 bovine serum Substances 0.000 description 1
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000032823 cell division Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 230000035602 clotting Effects 0.000 description 1
- 239000012228 culture supernatant Substances 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 1
- 229910000396 dipotassium phosphate Inorganic materials 0.000 description 1
- 235000019797 dipotassium phosphate Nutrition 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 210000004754 hybrid cell Anatomy 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 239000003547 immunosorbent Substances 0.000 description 1
- 238000009655 industrial fermentation Methods 0.000 description 1
- 238000001155 isoelectric focusing Methods 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- MYWUZJCMWCOHBA-VIFPVBQESA-N methamphetamine Chemical compound CN[C@@H](C)CC1=CC=CC=C1 MYWUZJCMWCOHBA-VIFPVBQESA-N 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 235000019426 modified starch Nutrition 0.000 description 1
- 230000009871 nonspecific binding Effects 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- CHKVPAROMQMJNQ-UHFFFAOYSA-M potassium bisulfate Chemical compound [K+].OS([O-])(=O)=O CHKVPAROMQMJNQ-UHFFFAOYSA-M 0.000 description 1
- 239000001120 potassium sulphate Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 239000007790 solid phase Substances 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 239000012085 test solution Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
- C12Q1/40—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving amylase
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/962—Prevention or removal of interfering materials or reactants or other treatment to enhance results, e.g. determining or preventing nonspecific binding
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/824—Immunological separation techniques
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/828—Protein A
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/808—Materials and products related to genetic engineering or hybrid or fused cell technology, e.g. hybridoma, monoclonal products
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/808—Materials and products related to genetic engineering or hybrid or fused cell technology, e.g. hybridoma, monoclonal products
- Y10S530/809—Fused cells, e.g. hybridoma
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Microbiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Medicinal Chemistry (AREA)
- Food Science & Technology (AREA)
- Cell Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicinal Preparation (AREA)
- Enzymes And Modification Thereof (AREA)
- Cephalosporin Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19833342736 DE3342736A1 (de) | 1983-11-25 | 1983-11-25 | Hybridoma-antikoerper |
Publications (2)
Publication Number | Publication Date |
---|---|
CS896784A2 CS896784A2 (en) | 1987-08-13 |
CS256383B2 true CS256383B2 (en) | 1988-04-15 |
Family
ID=6215298
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CS848967A CS256383B2 (en) | 1983-11-25 | 1984-11-22 | Reagent for specific determination of pancreas alpha-amylase |
Country Status (14)
Country | Link |
---|---|
US (1) | US4939082A (fi) |
EP (1) | EP0150309B1 (fi) |
JP (2) | JPS60155134A (fi) |
AT (1) | ATE44320T1 (fi) |
AU (1) | AU550266B2 (fi) |
CA (1) | CA1313150C (fi) |
CS (1) | CS256383B2 (fi) |
DD (1) | DD233142A5 (fi) |
DE (2) | DE3342736A1 (fi) |
DK (2) | DK162727C (fi) |
ES (1) | ES537835A0 (fi) |
FI (1) | FI83669C (fi) |
YU (1) | YU45971B (fi) |
ZA (1) | ZA849140B (fi) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4757001A (en) * | 1984-02-16 | 1988-07-12 | Fujirebio Kabushiki Kaisha | Method of measuring biological ligand by utilizing amylase |
DE3500526A1 (de) * | 1985-01-09 | 1986-07-10 | Boehringer Mannheim Gmbh, 6800 Mannheim | Spezifisch hemmender s-amylase-mak |
DE3508384A1 (de) * | 1985-03-08 | 1986-11-06 | Boehringer Mannheim Gmbh, 6800 Mannheim | Hemmung humaner speichel- und pankreasamylase durch monoklonale antikoerper |
DE3525926A1 (de) | 1985-07-19 | 1987-01-29 | Boehringer Mannheim Gmbh | Verfahren und reagenz zur spezifischen bestimmung von pankreas-alpha-amylase |
WO1987000526A1 (en) * | 1985-07-26 | 1987-01-29 | The University Of Virginia Alumni Patents Foundati | Immunochemical assays for human amylase isoenzymes and related monoclonal antibodies, hybridoma cell lines and production thereof |
DE3903114A1 (de) * | 1989-02-02 | 1990-08-09 | Boehringer Mannheim Gmbh | Verfahren zur bestimmung eines enzyms aus einem isoenzymgemisch sowie hierfuer geeigneter testtraeger und dessen verwendung |
DE3929355A1 (de) * | 1989-09-04 | 1991-03-07 | Boehringer Mannheim Gmbh | Verfahren zur spezifischen bestimmung von pankreas-(alpha)-amylase |
JPH085919B2 (ja) * | 1989-11-10 | 1996-01-24 | 日本商事株式会社 | 唾液―α―アミラーゼ活性阻害モノクローナル抗体およびそれを用いる膵臓―α―アミラーゼの分別定量法 |
GB9024970D0 (en) * | 1990-11-16 | 1991-01-02 | Genzyme Uk Ltd | Assay |
KR20030079382A (ko) * | 2002-04-04 | 2003-10-10 | 최태부 | 소화 효소-지방산 복합체를 항원으로하여 생산된 항체 및이의 이용 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2258822A1 (de) * | 1972-12-01 | 1974-06-06 | Merck Patent Gmbh | Verfahren und mittel zur analyse von isoenzymmustern |
JPS58183098A (ja) * | 1982-04-20 | 1983-10-26 | Wako Pure Chem Ind Ltd | アイソザイム分別定量法 |
DE3245665A1 (de) * | 1982-05-04 | 1983-11-10 | Boehringer Mannheim Gmbh, 6800 Mannheim | Verfahren zur herstellung permanenter tierischer und humaner zellinien und deren verwendung |
US4474892A (en) * | 1983-02-16 | 1984-10-02 | Board Of Trustees Of The Leland Stanford Junior University | Two-site immunoassays using monoclonal antibodies of different classes or subclasses and test kits for performing same |
DE3508384A1 (de) * | 1985-03-08 | 1986-11-06 | Boehringer Mannheim Gmbh, 6800 Mannheim | Hemmung humaner speichel- und pankreasamylase durch monoklonale antikoerper |
-
1983
- 1983-11-25 DE DE19833342736 patent/DE3342736A1/de not_active Ceased
-
1984
- 1984-11-21 ES ES537835A patent/ES537835A0/es active Granted
- 1984-11-22 CS CS848967A patent/CS256383B2/cs unknown
- 1984-11-22 YU YU196984A patent/YU45971B/sh unknown
- 1984-11-22 DK DK555584A patent/DK162727C/da not_active IP Right Cessation
- 1984-11-22 JP JP59246409A patent/JPS60155134A/ja active Granted
- 1984-11-22 CA CA000468445A patent/CA1313150C/en not_active Expired - Fee Related
- 1984-11-22 DD DD84269782A patent/DD233142A5/de not_active IP Right Cessation
- 1984-11-23 DE DE8484114172T patent/DE3478821D1/de not_active Expired
- 1984-11-23 AT AT84114172T patent/ATE44320T1/de not_active IP Right Cessation
- 1984-11-23 ZA ZA849140A patent/ZA849140B/xx unknown
- 1984-11-23 FI FI844608A patent/FI83669C/fi not_active IP Right Cessation
- 1984-11-23 EP EP84114172A patent/EP0150309B1/de not_active Expired
- 1984-11-26 AU AU35874/84A patent/AU550266B2/en not_active Ceased
-
1989
- 1989-03-21 US US07/326,885 patent/US4939082A/en not_active Expired - Lifetime
-
1990
- 1990-10-25 DK DK257690A patent/DK257690A/da not_active Application Discontinuation
-
1991
- 1991-06-07 JP JP3136054A patent/JPH05232117A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
JPH05232117A (ja) | 1993-09-07 |
DK257690D0 (da) | 1990-10-25 |
DK162727B (da) | 1991-12-02 |
ES8507568A1 (es) | 1985-09-16 |
FI83669C (fi) | 1991-08-12 |
JPH0436343B2 (fi) | 1992-06-15 |
JPS60155134A (ja) | 1985-08-15 |
US4939082A (en) | 1990-07-03 |
FI83669B (fi) | 1991-04-30 |
EP0150309A3 (en) | 1985-08-21 |
ATE44320T1 (de) | 1989-07-15 |
AU550266B2 (en) | 1986-03-13 |
CA1313150C (en) | 1993-01-26 |
DK257690A (da) | 1990-10-25 |
AU3587484A (en) | 1985-05-30 |
EP0150309A2 (de) | 1985-08-07 |
YU45971B (sh) | 1992-12-21 |
DK162727C (da) | 1992-05-11 |
DD233142A5 (de) | 1986-02-19 |
FI844608L (fi) | 1985-05-26 |
EP0150309B1 (de) | 1989-06-28 |
DE3342736A1 (de) | 1985-06-05 |
DK555584D0 (da) | 1984-11-22 |
DE3478821D1 (en) | 1989-08-03 |
ES537835A0 (es) | 1985-09-16 |
YU196984A (en) | 1989-12-31 |
CS896784A2 (en) | 1987-08-13 |
ZA849140B (en) | 1985-07-31 |
FI844608A0 (fi) | 1984-11-23 |
DK555584A (da) | 1985-05-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA1160566A (en) | Immunological determination method | |
JP3431140B2 (ja) | 抗体およびその使用方法 | |
US4863851A (en) | Monoclonal antibody to prostate secretory protein | |
CS256383B2 (en) | Reagent for specific determination of pancreas alpha-amylase | |
JPH0710238B2 (ja) | α−アミラ−ゼの測定法及び測定用試薬 | |
EP2141180B1 (en) | Antibody recognizing canine CRP and human CRP | |
JP2959837B2 (ja) | 癌関連ハプトグロビン | |
JP2925117B2 (ja) | 体液中の唾液アルファアミラーゼを除く膵液アルファアミラーゼを特異的に定量する方法および試薬 | |
JP2012082210A (ja) | Adamts13活性検定用抗体及び活性検定方法 | |
JPH05508835A (ja) | 慢性関節リウマチの免疫診断検定法 | |
US5573918A (en) | Process and reagent for specific determination of pancreatic alpha amylase | |
NO172084B (no) | Monoklonalt antistoff, anvendelse derav samt reagenssystem for immunologisk bestemmelse av fritt protein s og c4bp-protein s kompleks | |
US5858685A (en) | Prostate specific antigen from benign prostatic hyperplasia and its use in diagnosis | |
JPH0198968A (ja) | ヒス・インスリンの測定方法 | |
JP2868808B2 (ja) | 活性化血小板抗原測定試薬 | |
JP3451783B2 (ja) | コリンエステラーゼの測定法及び肝硬変と肝炎の識別法 | |
JPH0322945B2 (fi) | ||
JP4608570B2 (ja) | 新規なモノクローナル抗体及びニックβ2グリコプロテインIの免疫学的分析方法 | |
JPH0346116B2 (fi) | ||
JPS63151856A (ja) | ヒトプロテインsに対するモノクローナル抗体を用いた免疫学的測定試薬及びキット | |
WO1992016846A1 (en) | Collagen assaying method and kit | |
Henriques et al. | Screening of monoclonal antibodies to scarce and labile enzymes: A functional immunoassay for isolating monoclonal antibodies to NADPH: nitrate reductase | |
JPS61118663A (ja) | カリクレインの免疫学的測定法 | |
JPH0827282B2 (ja) | ヒト・プロテインcの免疫学的測定法,測定試薬およびそのキット | |
EP0506682A1 (en) | Method of determining anti-xanthine oxidase antibody |